A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

September 3, 2024

Study Completion Date

September 3, 2024

Conditions

Healthy Participants

Interventions

DRUG

Lu AF82422

Lu AF82422 solution for intravenous infusion

Trial Locations (1)

Zhongshan Hospital Fudan University, Shanghai

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT06258720 - A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults | Biotech Hunter | Biotech Hunter